Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.95 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

huiheng medical inc (HHGM) Snapshot

Open
$0.94
Previous Close
$0.95
Day High
$0.95
Day Low
$0.91
52 Week High
03/3/15 - $0.95
52 Week Low
05/13/14 - $0.45
Market Cap
13.4M
Average Volume 10 Days
17.7K
EPS TTM
$0.25
Shares Outstanding
14.1M
EX-Date
--
P/E TM
3.8x
Dividend
--
Dividend Yield
--
Current Stock Chart for HUIHENG MEDICAL INC (HHGM)

Related News

No related news articles were found.

huiheng medical inc (HHGM) Related Businessweek News

No Related Businessweek News Found

huiheng medical inc (HHGM) Details

Huiheng Medical Inc., through its subsidiaries, engages in the design and sale of precision radiotherapy equipment used for the treatment of cancerous tumors in the People’s Republic of China. It offers a line of gamma treatment systems that deliver conforming doses of radiation to the target tissue, and a multileaf collimator used in conjunction with a linear accelerator for radiation therapy applications. The company’s products include the Super Gamma System, a radiotherapy device that uses gamma radiation to non-invasively treat tumors located in the head and the body, and to treat certain functional disorders of the head and neck areas; the Body Gamma Treatment System, a stereotactic radiotherapy device that uses gamma sourced radiation to non-invasively treat tumors located in the body; and OPEN Stereotactic Gamma-ray Radiotherapy System. Its products also comprise the Head Gamma Treatment System, a stereotactic radiotherapy device that uses gamma sourced radiation to non-invasively treat tumors in the head and to treat other functional disorders of the head and neck area, as well as a multileaf collimator device used in conjunction with a linear accelerator for radiation therapy applications. In addition, the company offers post-sale services, including radioactive cobalt source replacement and disposal, medical expert training, clinical trial analysis, patient tumor treatment analysis, software upgrades, and patient care consulting for its own products, as well as the products manufactured by others. Huiheng Medical, Inc. sells its products to third party hospital equipment investors; and maintenance and service contracts to its distributors. The company is based in Shenzhen, the People’s Republic of China.

78 Employees
Last Reported Date: 04/24/12

huiheng medical inc (HHGM) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HHGM:US $0.95 USD 0.00

HHGM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for HHGM.
View Industry Companies
 

Industry Analysis

HHGM

Industry Average

Valuation HHGM Industry Range
Price/Earnings 3.4x
Price/Sales 1.7x
Price/Book 0.5x
Price/Cash Flow 3.0x
TEV/Sales 1.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HUIHENG MEDICAL INC, please visit www.huihengmedical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.